GDF2 and metabolic dysfunction-associated steatotic liver disease: A thorough comprehension of BMP9 will significantly enhance our understanding of viral hepatitis, acute liver injury, obesity, T2DM, NAFLD, liver fibrosis or cirrhosis, PoPH, and HCC, potentially establishing it as a valuable biomarker for diagnosing and monitoring various liver diseases.